Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Gruel

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Surgery|August 31, 2000
Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactionsB Khalfoun, D Barrat, H Watier, et al.
Vox Sanguinis|September 2, 2016
Post-authorization safety study of Clottafact<sup>®</sup> , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational studyC Négrier, C Rothschild, J-Y Borg, et al.
Journal of Thrombosis and Haemostasis : JTH|July 13, 2012
The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIIIP Lapalud, T Ali, C Cayzac, et al.
Revue Des Maladies Respiratoires|October 16, 2018
[Risk factors for thromboembolic disease in young women-the role of hormones]C Tromeur, R Le Mao, P Jego, et al.
Thrombosis Journal|September 14, 2020
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratoryM Hardy, T Lecompte, J Douxfils, et al.
Anaesthesia, Critical Care & Pain Medicine|October 27, 2018
Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR)A Godier, D Garrigue, D Lasne, et al.
Annales Francaises D'Anesthesie Et De Reanimation|September 3, 2013
[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013]G Pernod, P Albaladejo, A Godier, et al.
Vox Sanguinis|December 15, 2017
Postauthorization safety study of Clottafact<sup>®</sup> , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational studyC Négrier, A-S Ducloy-Bouthors, V Piriou, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 25, 2016
[Neonatal arterial ischemic stroke: Review of the current guidelines]E Saliba, T Debillon, , et al.
Revue Des Maladies Respiratoires|October 24, 2008
[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]F Couturaud, G Pernod, C Pison, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Surgery|August 31, 2000
Development of an ex vivo model of pig kidney perfused with human lymphocytes. Analysis of xenogeneic cellular reactionsB Khalfoun, D Barrat, H Watier, et al.
Vox Sanguinis|September 2, 2016
Post-authorization safety study of Clottafact<sup>®</sup> , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational studyC Négrier, C Rothschild, J-Y Borg, et al.
Journal of Thrombosis and Haemostasis : JTH|July 13, 2012
The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIIIP Lapalud, T Ali, C Cayzac, et al.
Revue Des Maladies Respiratoires|October 16, 2018
[Risk factors for thromboembolic disease in young women-the role of hormones]C Tromeur, R Le Mao, P Jego, et al.
Thrombosis Journal|September 14, 2020
Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratoryM Hardy, T Lecompte, J Douxfils, et al.
Anaesthesia, Critical Care & Pain Medicine|October 27, 2018
Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR)A Godier, D Garrigue, D Lasne, et al.
Annales Francaises D'Anesthesie Et De Reanimation|September 3, 2013
[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013]G Pernod, P Albaladejo, A Godier, et al.
Vox Sanguinis|December 15, 2017
Postauthorization safety study of Clottafact<sup>®</sup> , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational studyC Négrier, A-S Ducloy-Bouthors, V Piriou, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 25, 2016
[Neonatal arterial ischemic stroke: Review of the current guidelines]E Saliba, T Debillon, , et al.
Revue Des Maladies Respiratoires|October 24, 2008
[Prolongation of anti vitamin K treatment for 18 months versus placebo after 6 months treatment of a first episode of ideopathic pulmonary embolism: a mutlicentre, randomised double blind trail. The PADIS-EP Trial]F Couturaud, G Pernod, C Pison, et al.
Pageof 14